Orica-GreenEdge rider Simon Yates has tested positive for Terbutaline on the final stage of Paris-Nice with the team doctor failing to apply for a Therapeutic Use Exemption (TUE).
In a statement, Orica-GreenEdge said it takes full responsibility for the failed test. The team statement said Orica-GreenEdge was notified on April 22 that Simon Yates has an adverse analytical finding from a test conducted at Paris-Nice, stage 6 on March 12, 2016 and added the positive result is for the substance Terbutaline.
The statement further reads that the substance was given to Simon Yates in the form an asthma inhaler and accordingly it was noted by the team doctor on the Doping Control Form, signed at the time of the test. It was further remarked that the substance was given in an ongoing treatment of Simon Yates' documented asthma problems but the team doctor made an administrative error by failing to apply for the TUE required for the use of this treatment. The Orica-GreenEdge also reads that the use of Terbutaline without a current TUE is the reason it has been flagged as an adverse analytical finding and this is solely based on a human error that the doctor in question has taken full responsibility for.
It was also remarked that there has been no wrongdoing on the part of Simon Yates and the Orica-GreenEdge team takes complete responsibility for this error and wishes to underline their support during this process for Yates. It was also said that the professional cycling team is concerned by the leak of this information and has presently no further comments until a full evaluation is made of the statements, documents, and evidence that Simon Yates and the team are now submitting to the world governing body of the cycling to clarify everything.
A British Cycling spokesman said British Cycling can confirm that it has been notified by the UCI of a potential anti-doping rule violation against a British rider based on an analysis of a sample provided in-competition. The spokesman added those proceedings, as with any other doping violation charge at this level, will be managed independently of British Cycling by the UCI and also commented that it would be inappropriate to comment further until the process has been completed.
A UK Anti-doping spokeswoman said UK Anti-Doping does not discuss or disclose details of any cases until due legal process has been completed and an anti-doping rule violation is deemed to have been committed. The spokesman added details of all anti-doping rule violations are published on our website once the legal process is complete.
This doping news is another setback for British Cycling that is already in turmoil over the recent resignation of technical director Shane Sutton amid allegations he used sexist language and made use of derogatory comments, just months from the Rio Olympics.
The 23-year-old from Bury is among Britain's brightest prospects. Yates finished 2015 as the best young rider in the Tour of the Basque Country and the Criterium du Dauphine. Simon is the older twin and his brother Adam also races for Orica-GreenEdge and Britain.